These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 32977524)

  • 1. "Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy.
    Rovina D; Castiglioni E; Niro F; Mallia S; Pompilio G; Gowran A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
    Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
    Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
    Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy.
    Afzal MZ; Reiter M; Gastonguay C; McGivern JV; Guan X; Ge ZD; Mack DL; Childers MK; Ebert AD; Strande JL
    J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):549-562. PubMed ID: 26940570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
    Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
    Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilated cardiomyopathy and the dystrophin gene: an illustrated review.
    Oldfors A; Eriksson BO; Kyllerman M; Martinsson T; Wahlström J
    Br Heart J; 1994 Oct; 72(4):344-8. PubMed ID: 7833192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on the road to modelling cardiomyopathy in muscular dystrophy.
    Canonico F; Chirivi M; Maiullari F; Milan M; Rizzi R; Arcudi A; Galli M; Pane M; Gowran A; Pompilio G; Mercuri E; Crea F; Bearzi C; D'Amario D
    Cardiovasc Res; 2022 Jun; 118(8):1872-1884. PubMed ID: 34254111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
    Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
    J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.
    Lee YK; Jiang Y; Ran XR; Lau YM; Ng KM; Lai WH; Siu CW; Tse HF
    Stem Cell Res Ther; 2016 Sep; 7(1):139. PubMed ID: 27649756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies.
    Abati E; Sclarandi E; Comi GP; Parente V; Corti S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of circular RNAs with host gene-independent expression in human model systems for cardiac differentiation and disease.
    Siede D; Rapti K; Gorska AA; Katus HA; Altmüller J; Boeckel JN; Meder B; Maack C; Völkers M; Müller OJ; Backs J; Dieterich C
    J Mol Cell Cardiol; 2017 Aug; 109():48-56. PubMed ID: 28676412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy.
    Mirabella M; Servidei S; Manfredi G; Ricci E; Frustaci A; Bertini E; Rana M; Tonali P
    Neurology; 1993 Nov; 43(11):2342-5. PubMed ID: 8232953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.
    Wasala NB; Shin JH; Lai Y; Yue Y; Montanaro F; Duan D
    Hum Gene Ther; 2018 Jul; 29(7):737-748. PubMed ID: 29433343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-editing, immunological and iPSCs based therapeutics for muscular dystrophy.
    Singh S; Singh T; Kunja C; Dhoat NS; Dhania NK
    Eur J Pharmacol; 2021 Dec; 912():174568. PubMed ID: 34656607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells.
    Payne TR; Oshima H; Sakai T; Ling Y; Gharaibeh B; Cummins J; Huard J
    Gene Ther; 2005 Aug; 12(16):1264-74. PubMed ID: 15843810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy.
    Yoshida K; Ikeda S; Nakamura A; Kagoshima M; Takeda S; Shoji S; Yanagisawa N
    Muscle Nerve; 1993 Nov; 16(11):1161-6. PubMed ID: 8413368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of hypertrophic and dilated cardiomyopathy.
    Marian AJ; Roberts R
    Tex Heart Inst J; 1994; 21(1):6-15. PubMed ID: 8180512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of cardiac muscle involvement and the dystrophin gene abnormality in Becker muscular dystrophy].
    Yazaki M; Nakamura A; Yoshida K; Ikeda S
    Nihon Rinsho; 1997 Dec; 55(12):3142-7. PubMed ID: 9436425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.